NHNSENarayana Hrudayalaya Ltd.· Healthcare ServicesHighNeutral
Announced Mon, 3 Nov, 2025 · 19:21 IST

Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation

Promoter Disclosed Acquisition PlansInvestor Communications View source PDFExplain this filing

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.8%Reaction day
₹1782.90
prior close
₹1792.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%+3.5% vs market
Hospital peers, median of 19sector-0.2%+3.0% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Smallcap 250 and 3.0 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.7
10m
+0.1
15m
-0.0
30m
+0.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.8-0.7+3.5-0.2+3.0
Next day
+2.4-2.1+4.5-0.9+3.2
2d
+1.6-2.4+4.0-0.8+2.5
3d
+1.5-2.4+3.9-3.2+4.7
4d
-1.1-2.5+1.4-4.0+2.9
5d
-1.3-1.8+0.5-4.0+2.6
1w
-1.5-2.0+0.6-2.9+1.4
15d
+10.5-3.5+14.0-4.1+14.6
1m
+8.8-4.9+13.7-5.3+14.1
2m
+6.3-3.4+9.7-9.5+15.8
3m
-1.3-7.7+6.4-15.5+14.2
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 19Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Narayana Hrudayalaya has filed a revised investor presentation detailing its 100% acquisition of UK-based Practice Plus Group (PPG) Hospitals Limited for approximately GBP 183 million, implying a 9.2x FY25E EV/EBITDA multiple. PPG is the 5th largest private healthcare network in the UK and 4th largest NHS service provider, with FY25E revenue of GBP 250 million and a 12% revenue CAGR over the past 5 years. The deal is largely debt-funded with about GBP 150 million raised through long-term debt with a 7-year tenor. The transaction requires no pre-closing regulatory approvals and is expected to close within a few days, supported by a 6-month transition services agreement. The company views this as a low-risk, value-accretive entry into the mature UK private healthcare market, leveraging its asset-light day-care model and NHS contracts.

Likely market impact

Shareholders should view this as a significant international expansion that diversifies revenue beyond India, but the GBP 150 million debt component will increase leverage, even though the asset-light target offers clear deleveraging potential. Near-term stock reaction may depend on investor comfort with the 9.2x valuation multiple and integration execution.